Abstract

Aggregation of the neurotoxic amyloid beta peptide 1-42 (Abeta-(1-42)) in the brain is considered to be an early event in the pathogenesis of Alzheimer's disease (AD). Par-4 (prostate apoptosis response-4) is a leucine zipper protein that is pro-apoptotic and associated with neuronal degeneration in AD. Overexpression of Par-4 significantly increased production of Abeta-(1-42) after initiation of apoptotic cascades, indicating factors regulating apoptotic pathways may also affect processing of beta-amyloid precursor protein (APP). AATF (apoptosis-antagonizing transcription factor) was recently identified as an interaction partner of DAP-like kinase (Dlk), a member of the DAP (death-associated protein) kinase family. AATF antagonizes apoptosis induced by Par-4, suggesting that AATF might directly or indirectly participate in regulation of Par-4 activity. We now report that AATF colocalizes with Par-4 in both cytoplasmic and nuclear compartments, and it interacts directly and selectively with Par-4 via the leucine zipper domain in neural cells. Par-4 induced an aberrant production and secretion of Abeta in neuroblastoma IMR-32 cells after apoptotic cascades are initiated. Co-expression of AATF completely blocked aberrant production and secretion of Abeta-(1-42) induced by Par-4, and AATF/Par-4 complex formation was essential for the inhibitory effect of AATF on aberrant Abeta secretion. These results indicate that AATF is an endogenous antagonist of Par-4 activity and an effective inhibitor of aberrant Abeta production and secretion under apoptotic conditions.

Highlights

  • It is widely accepted that neuronal degeneration in Alzheimer’s disease (AD)1 may be caused by extracellular accumulation of aggregated, neurotoxic amyloid ␤ peptide 1– 42 (A␤-(1– 42), Refs. 1–13)

  • We report that AATF interacts directly with Par-4 via the leucine zipper domain, and blocks Par-4 mediated aberrant production of A␤-(1– 42) in IMR-32 cells

  • Mutations in amyloid precursor protein (APP) and presenilins, which are implicated in the pathogenesis of familial AD and neuronal apoptosis, significantly increase the production of A␤-(1– 42) (14 –27)

Read more

Summary

Introduction

It is widely accepted that neuronal degeneration in Alzheimer’s disease (AD) may be caused by extracellular accumulation of aggregated, neurotoxic amyloid ␤ peptide 1– 42 (A␤-(1– 42), Refs. 1–13). Mutations in familial Alzheimer’s disease (FAD) genes, such as ␤-amyloid precursor protein (APP) and presenilin-1. Par-4 (prostate apoptosis response-4) is a leucine zipper protein that was associated with neuronal degeneration in Alzheimer’s disease (28 – 49). Overexpression of Par-4 in neuroblastoma IMR-32 cells significantly increased production of A␤-(1– 42) through a caspase-dependent pathway [40]. These results suggest that Par-4 is involved in the abnormal processing of APP during the apoptotic process. We report that AATF interacts directly with Par-4 via the leucine zipper domain, and blocks Par-4 mediated aberrant production of A␤-(1– 42) in IMR-32 cells. Selective enhancement of AATF expression in neuronal cells may provide a potential therapeutic approach for aberrant production of A␤-(1– 42) in AD

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call